Craniopharyngioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

ACTEMRA ® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Conditions:   Adamantinomatous Craniopharyngioma;   Recurrent Adamantinomatous Craniopharyngioma Intervention:   Drug: Tocilizumab Sponsors:   Nationwide Children's Hospital;   Children's Hospital Colorado Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2022 Category: Research Source Type: clinical trials

Craniopharyngioma With Tumoral Hemorrhage
Conditions:   Craniopharyngioma;   Apoplexy Intervention:   Other: intratumoral hemorrhage Sponsor:   Tongji Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2021 Category: Research Source Type: clinical trials